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ABSTRACT Instances when T cell activation via the T cell receptor/CD3 complex is suppressed by anti-CD4 Abs are generally
attributed either to the topological separation of CD4-p561ck from CD3, or their improper apposition. Photobleaching fluorescence
resonance energy transfer measurements permitted direct analysis of these alternatives on human peripheral blood lympho-
cytes. Distinction between changes of relative antigen densities or positioning was made possible by simultaneously recording
donor and acceptor fluorescence in the energy transfer experiment performed on homogeneous populations of flow-sorted cells.
We show here that CD4 stays in the molecular vicinity of CD3, while anti-CD3 stimulation is suppressed by anti-CD4 or
cross-linked HIV gp120. Our data suggest that cross-linking of CD4 through particular epitopes is capable of inhibiting activation
driven by Abs binding to specific sites on CD3 without major topological sequestration of the Ags, in such a way that additional
positive signals will also be affected. Thus, these and other related cases of negative signaling via CD4 may be interpreted in
terms of functional uncoupling rather than a wide physical separation of CD4 from the T cell receptor-CD3 complex.
INTRODUCTION
T cell activation evoked via the T cell receptor/CD3 (TCR/
CD3) complex is normally potentiated by co-engagement of
CD4 mediated by major histocompatibility complex (MHC)
class II molecules of the Ag-presenting cell (Dianzani et al.,
1992; Haque et al., 1987; Mittler et al., 1989; Rojo et al.,
1989; Saizawa et al., 1987; Kupfer et al., 1987). CD4 appears
to deliver an activated protein tyrosine kinase p561Ck, non-
covalently attached to its cytoplasmic end, to TCR/CD3 upon
their co-aggregation (Abraham et al., 1991; Veillette et al.,
1988; Rudd et al., 1988; Straus and Weiss, 1992; Collins
et al., 1992; Glaichenhaus et al., 1991). Anti-CD4 Abs
(Janeway, 1989; Newell et al., 1990; Bank and Chess, 1985),
even fragments involved in antigen binding (Fab; Haque
et al., 1987) and peptide fragments of the CD4 molecule
(McDonnell et al., 1992), have been described as exhibiting
a negative effect on T helper cell activation elicited by certain
anti-TCR/CD3 Abs or Ag. At an early stage of activation, its
suppression by CD4ligation may be explained by (1) steric
separation (Newell et al., 1990; Nel et al., 1990; Haughn
et al., 1992) of the TCR/CD3 complex from CD4; or (2)
specific conformational-topological constraints (Haughn
et al., 1992) imposed on the TCR/CD3/CD4 complex. This
latter condition either (2a) prevents the development of an
active TCR/CD3 conformation (Rojo and Janeway, 1988)
elicited normally by MHC, or (2b) may represent a negative
signal (Newell et al., 1990; Bank and Chess, 1985) that coun-
teracts activation via productively engaged receptors of the
same cell (or same multi-receptor complex). The special case
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of model 1, when minimal spatial separation would prevent
direct contact of the Ags (without their large-scale seques-
tration as visualized in cocapping experiments), appears
functionally equivalent to model 2. Up until now, it has not
been possible to distinguish between broad physical seques-
tration and functional uncoupling of TCR/CD3 and CD4 or
steric distortion of the complex.
A highly sensitive version (SzabO et al., 1992a; see
Materials and Methods for recent modifications) of the pho-
tobleaching fluorescence resonance energy transfer method
(pFRET; Jovin and Arndt-Jovin, 1989)) permitted the meas-
urement of molecular distances between receptor-bound
Abs, and enabled us to distinguish between the above pos-
sibilities on peripheral blood leukocytes (PBL). FRET tech-
niques are applied to measure the efficiency (E) of the trans-
fer of excitation energy from an excited donor to a proximal
acceptor, according to the E = R06/(Ro6 + ~) equation, used
as a molecular ruler for the donor-acceptor distance (with Ro
= 10 nm in our case; see Szabo et al., 1992a). We showed
that phycoerythrin (PE, attached to antibody), is a very ef-
ficient acceptor when fluorescein is the donor (conjugated
with another antibody as its isothiocyanate, FITC). The pho-
tobleaching version of this technique is based on the finding
(Jovin and Arndt-Jovin, 1989) that the kinetics of photo-
bleaching are slower when a spectrally adequate energy ac-
ceptor is in close proximity to the donor. We have recently
further developed this approach to carry out pFRET mea-
surements in a laser microscope system (Szabo et al., 1992a).
The utility of the technique in detecting intramolecular con-
formational changes of CD4 (SzabO et al., 1992b), and the
Leu8 antigen (SzabO et al., 1993) on human peripheral blood
T cells has been demonstrated.
In the present work we approximate the degree and pattern
of redistribution of cell surface molecules (CD4, TCR, CD3)
upon treatment with various antibodies, used for treatment
and as fluorescent label at the same time, demonstrating the
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method's utility for the assessment of intermolecular dis-
tances on human PBL. Since E is measured on the donor side
in pFRET, its value is a function ofboth the (inherently large)
cell-to-cell variations of the donor/acceptor ratio, and of the
changing topology (with antigen densities maintained). To
distinguish between these alternatives we measured both the
donor and acceptor fluorescence, performing pFRET on
homogeneous samples of flow-sorted cells.
MATERIALS AND METHODS
Cells
PBL of healthy donors were prepared from the interface of Histopaque-1077
(Sigma Chern. Co., St. Louis, MO, USA) gradients. 3H-thymidine incor-
poration was measured using 0.5 /JoCi/microwell 86 Ci/mmol isotope (Am-
ersham, UK) in 4-h pulses, after 3 days of culturing in RPMI 1640 + 10%
FCS, glutamine, penicillin, and streptomycin, and monoclonal Abs (mAbs).
The anti-CD3 Abs Leu4, and wt31 (product name: anti-TCRa/f3) were from
Becton Dickinson (Mountain View, CA), UCHTI was from DAKO Corp.
(Carpinteria, CA). OKTI (anti-CD3), as well as the TCRa/f3-specific
OKTIa were from Ortho Diagnostic Systems, Inc. (Raritan, NJ). The fol-
lowing CD4-specific antibodies and ligands were used: Leu3a (Becton
Dickinson), OKT4a, and OKT4 (Ortho Diagnostic Systems), Sim.4 (AIDS
Research and Reference Reagent Program NlAID, NIH, Bethesda, MD);
Abs 463 and 818, recombinant gpI20-HSV chimeric protein, and anti-HSV
Ab 5B6 were from Genentech, Inc. (South San Francisco, CA). For im-
munostaining ofcells, usually 100 ng of the Abs from Becton Dickinson and
DAKO, or 1 /Jog of OKT4E or OKT3a were used, except where noted. The
mC/protein ratios ofall the Abs used were between 4 and 5. Fluorochrome-
conjugated Abs were added to 1 X 106 cells in 0.1 ml phosphate-buffered
saline (PBS, pH 7.4) and incubated for 30 min on ice. In some experiments
(Table 1), fluorochrome-conjugated Abs were added to PBL in complete
medium at the usual cell concentration of 1 X 106 cells/ml and allowed to
act on the cells (Abs used as treatment) as well as label them, for 30 min.
The cells were washed twice with ice-cold PBS and fixed for 1 h in 1%
paraformaldehyde (in PBS), followed by flow-cytometric (FACScan
(Becton Dickinson, used with the "Research software", or software version
"Consort 30") or Coulter Corp. (Hialeah, FL) Elite V) analysis and sepa-
ration (Coulter) from ice-cooled tubes onto slides, for immediate pFRET
analysis in the ACAS 570 system (see below).
pFRET measurements
Photobleaching data collection for pFRET (Jovin and Arndt-Jovin, 1989,
Szab6 et aI., 1992a, b, 1993» was performed basically as described (see
Szab6 et al., 1992a) with several modifications, however, as pointed out
below, on an ACAS 570 stage scanning laser (fluorescent) microscope (Me-
ridian Instruments, Okemos, MI), using an Olympus looX oil immersion
objective lens (Olympus Corp. San Francisco, CA). The cells were posi-
tioned in the center of a laser illumination spot expanded by a beam diffuser
to a size of 30 /Jom in diameter. The argon laser was set for 1000 mW at 488
nm. Fluorescence intensity data, from the mc as well as from the PE
channel, were collected using the "point scan" mode of the ACAS Kinetics
Analysis software (version 2.0h). mc bleaching curve data were extracted
from the 2000 points of the ACAS • .kpt data file, smoothed and fitted to
a double exponential equation. The fitted data set of 100 data points and the
parameters of the fitted equation were imported into a spreadsheet program
(Quattro Pro 3.0, Borland Inc., Scotts Valley, CA).
The fixed donor-only and donor-+-acceptor (D, D + A)-labeled cells
were flow sorted from identical FLI (FITC) and FL2 (PE) windows for the
analysis of donor photobleaching kinetics. E was measured using the
E=I-~
1';vg
TABLE 1 Ab-Ab distance measurements by pFRET, with
samples prepared by flow sorting
Donor E' or ilE'
(expt. no.) Acceptor Treatment (expts. 5-7) E
OKT3a (1) Leu3a 15.2 :!: 2.2 17.5
OKTIa (1) Leu3a wt31 23.0:!: 2.0 23.0
OKTIa (2) Leu3a 10.3 :!: 1.2 10.3
OKTIa (2) Leu3a wt31 30.8:!: 0.8 33.9
OKTIa (2) Leu3a wt31 + Leu3a 31.3 :!: 1.0 35.2
OKTIa (2) Leu3a Leu4 31.6 :!: 0.8 36.1
OKTIa (2) Leu3a Leu4 + Leu3a 30.6:!: 0.9 35.9
OKTIa (1-4) Leu3a 9.0:!: 2.4
OKT4 (5-7) Leu4 gp120 + X 3.5 :!: 0.4
Leu3a (8) UCHTI 6.0:!: 1.2
Leu3a (8) UCHTI UCHTI 8.9:!: 1.2
Leu3a (8) UCHTI UCHTI + Leu3a 15.5 :!: 1.1
Leu3a (8) Leu4 Leu4 20.8:!: 1.3
Leu3a (8) Leu4 Leu4 + Leu3a 31.5 :!: 1.1
OKT3a (9) CD45RO -0.5:!: 2.4
wt31 (10) Leu3a wt31 + Leu3a 17.9:!: 1.7 17.9
Leu4 (10) Leu3a Leu4 + Leu3a 9.4 :!: 1.1 10.4
wt31 (11) Leu3a wt31 + Leu3a 14.4 :!: 1.5 14.4
Leu4 (11) Leu3a Leu4 + Leu3a 8.4 :!: 1.1 9.2
wt31 (12) Leu3a wt31 + Leu3a 12.2 :!: 1.2 12.2
Leu4 (12) Leu3a Leu4 + Leu3a 8.6:!: 1.0 9.9
OKT4E (13) UCHTI UCHTI 8.8:!: 2.9
OKT4E (13) Leu4 Leu4 15.7:!: 2.2
Changes of the E' observed energy transfer efficiency values are directly
indicative of topological changes in the case of experiments 8 and 13; the
(normalized) E values are informative in the other experiments (see Ma-
terials and Methods). Fluorescence labeling of 106 PBL was performed
either in PBS at O°C, or at 37°C in complete medium for 30 mins when these
Abs also served for a treatment (e.g., with Leu3a-PE in experiment 2). Leu4
doses producing approximately wt31-equivalent fluorescence were applied
in the case of experiments 10-12. SE was calculated for n = 49 (applying
the error propagation function on the primary SE values of T.y ;), or between
batches (experiments 1-4 and 5-7). ilE' = change of E' (experiments 5-7).
relationship (with T.yg and T,yg representing the average (SzabO et aI., 1992a)
half-lives of the donors upon bleaching in the absence and in the presence
of a proximal A, respectively). The subscript refers to the fact that double-
exponential fluorescence-decay kinetics are observed, and the average of the
two time constants weighted by the corresponding amplitudes provides T.yg
(see Szab6 et aI., 1992a). Depletion of the excited states due to FRET is
reflected in the prolongation of the T;yg value (relative to T.y ;), making the
calculation ofE possible, according to the above equation. The FLI and FL2
decay were registered simultaneously and the
r' = FLlml<gral
FL2 initial
relative D/A fluorescence (cell labeling) ratios were calculated for each
curve (cell), after subtracting the post-bleach (background) levels of green
and red fluorescence. (The fluorescein/protein ratios for each FITC con-
jugate used were between 4 and 5, based on batch-specific data, a courtesy
of Becton Dickinson.) Their r average for the 50 (D + A)-labeled cells was
used to obtain E (true energy transfer efficiency) from E' (efficiency cal-
culated directly from the observed decay time constants), in the normal-
ization procedure discussed below. The overestimation of r (just as its high
true (real) value) incurs low transfer efficiencies, depriving the method of
its sensitivity, while its underestimation would exaggerate small differences
in E. The calculated r values themselves were normalized to r = 1. A value
of r = 1 was assumed for the E determinations within each data set where
E measured and calculated for the CD3-to-CD4 transfer rendered E values
r = 1 : CD3 CD4 CD3--CD4
r > 1 or r < 1 : CD3 CD3--CD4 or CD4 CD3--CD4
similar to those measured in the opposite direction (from CD3 to CD4).
Relative r values were calculated for the rest of the data within that set. E
is independent from the direction of transfer at r = 1, whereas it strongly
depends on the direction of transfer at rvalues different from 1, as illustrated
below:
B
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(Complete independence or specific association of the Ags involved are
the two possible alternatives considered here; using FL2 (initial intensity-
background) as a measure of A labeling of the cells carries a minor error
due to energy transfer itself.)
Assuming a 1:1, specific D-A association that involves most of the avail-
able partner molecules present at the smaller (limiting) concentration, the
following two cases are considered. 1) When A 20 D (and the surplus A is
outside FRET distance from D), T avg (and E) will be invariant to r. Thus,
in the case of an anti-CD4 donor and anti-TCR/CD3 acceptor, E' will in-
dicate the D-A proximity within these complexes. 2) If D > A (i.e., there
is a population of free Ds; anti-TCR/CD3 donor and anti-CD4 acceptor),
T' cbs (observed, apparent T avg) and E', respectively, will be sensitive to
D/A = r, because
E' = 1-~
T cbs
and
T cbs = (A * T~vg + (D - A) * Tavg)/D
with T' cbs expressed as the average of decay time constants weighted by the
complexed and uncomplexed Ds, according to their respective ratios. From
the above, E within the D-A complexes presents (at r 20 1):
A
FIGURE 1 Schematic representation of the T helper cell surface. wt,
overlapping binding sites ofwt31, Leu4, and UCHT1; gp, overlapping bind-
ing sites of HIV gp120, the Leu3a, OKT4a and SimA mAbs; 3a, OKT3a
specific for TCRa/l3; OKT4, membrane proximal OKT4 epitope. Arrows
connect juxtaposed or distant TCR/CD3 and CD4 receptors, on the scale of
fluorescence resonance energy transfer. The rectangular symbols represent
receptor doublets assumed to be present to account for their capping by
mAbs. (A) Some CD4s are associated with TCR/CD3 complex, which is a
substrate for the lck kinase attached to CD4. (8) CD4s are sequestered by
their cross-linking.
E'
E = r * -----,------,--------"
1 + (r - 1) * E'
In order to assess the degree and changes of intimacy between D and A,
the (corrected) E values are to be compared in case 2 (anti-TCR/CD3 D,
anti-CD4 A), when differences in D/A strongly influence E, even without
changes in D-to-A proximity. The (observed) E' will be indicative of this
relationship when 1 seems to be the case (anti-CD4 D, anti-TCR/CD3 A),
i.e., in the absence of uncomplexed (solitary) D. Saturation of the available
D and A sites with Abs is assumed in the above model.
To further minimize biological variation, cells from samples to be com-
pared were sorted from identical FLl and FL2 windows for immediate
pFRET analysis. In addition, the cell-to-cell distribution of the FLI integral
values, as well as that of the Tavg and T' cbs' were always evaluated in cor-
relation with various other parameters (time of data collection, FL2, etc.)
on the worksheet program (Quattro) to recognize possible cell-to-cell het-
erogeneities and instrument instability. The experiments had been devised
to compare parallel samples of the same batch of cells labeled and measured
in alternating sequence on the same day. In our system, comparison of up
to four sample pairs (D- and (D + A)-labeled cells) was made possible on
a daily basis.
RESULTS
Epitope-specific inhibition of anti-CD3-stimulation
of PBl by CD4 cross-linking
Anti-CD3-induced activation of PBL was strongly inhibited
by CD4ligation, as shown in Fig. 2; see Fig. 1 for illustration
of the epitope specificities of the mAbs discussed below. The
Leu3a Ab (IgG1), specific for a CD4 epitope overlapping the
HIV gp120 binding site (Sattentau et aI., 1986) suppressed
wt31 (anti-CD3, IgG1) stimulation dramatically. This inhi-
bition was dose-dependent (Fig. 2 A). The effect of CD4
ligation on Leu4 (also anti-CD3, IgG1) stimulation was much
less marked, or on some batches of PBL, even stimulatory
(see Fig. 2 A and Table 2).
Fig. 2 B demonstrates that treatment of PBL with gp120
+ anti-gp120 had an effect identical with that of Leu3a, or
the competing (Sattentau et aI., 1986) OKT4a and SimA
(Table 2). At the same time, gp120 alone decreased activa-
tion to a lesser extent, probably due to the CD4 conforma-
tional change shown to result from binding of gp120 (Szabo
et aI., 1992b). The requirement for cross-linking in the case
of gp120 treatment to completely suppress wt31-evoked
stimulation suggested that cross-linking, and not just the li-
gation of CD4, was necessary for this effect. However, sev-
eral bivalent anti-CD4 Abs (e.g., OKT4; see Table 2) failed
to affect stimulation in a similar fashion. (We could directly
demonstrate the cross-linking effect of OKT4, using OKT4-
FITC and OKT4-PE as the D-A pairs, data not shown.) Thus,
cross-linking of CD4 in an epitope-specific manner was re-
sponsible for suppression.
On the other hand, the specificity of the anti-TCR/CD3 Ab
determined the outcome of anti-CD4 co-treatment. Stimu-
lation evoked by OKT3a (anti-TCRa/l3) was not inhibited
(see Table 2). Activation via anti-CD3 Abs OKTI or Leu4
was only mildly inhibited or even augmented, whereas ac-
tivation by wt31 and UCHT1 was inhibited by 75-95%, al-
though Leu4, OKT3, UCHT1, and wt31 appear to recognize
overlapping epitopes formed by the E plus 'Y or S chain
(Salmeron et aI., 1991). Thus, stimulation of PBL by mAbs,
competing for mutually exclusive binding sites on CD3, was
differentially affected by CD4 cross-linking. The extent of
inhibition did not correlate with the level of stimulation,
which showed great PBL batch-to-batch variability for both
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proximity relationships
Fig. 1 illustrates two antithetical cell surface topological ar-
rangements: with CD4 staying in the molecular vicinity of
TCR/CD3 (Fig. 1 A), or becoming sequestered (Fig. 1 B).
(Association of CD4 with TCR/CD3 is assumed to occur
upon activation; see Dianzani et aI., 1992; Haque et al., 1987;
Mittler et aI., 1989; Rojo et aI., 1989; Saizawa et aI., 1987;
Kupfer et aI., 1987). Broad spatial sequestration of cross-
linked CD4 away from TCR/CD3 would be reflected in the
absence of fluorescence energy transfer between anti-TCR/
CD3 Abs and anti-CD4 Abs. In contrast, a detectable level
of energy transfer would be compatible with model 2 above,
or the special case of model 1 when a small separation would
prevent direct contact of the Ags without their extensive se-
questration. Performing pFRET (Jovin and Arndt-lovin,
1989) adapted to a laser scanning image analyzer system
(Szab6 et aI., 1992a), using FITC-Iabeled mAb as the donor
(D) and PE-tagged Ab as the acceptor (A), allowed us to
address this question on PBL. Because the energy transfer
efficiency also depends upon the DIA ratio, we compared
samples flow sorted from identical sort windows and also
(cross-linked) wt31 was largely diminished by gp120 + anti-
gp120 or OKT4a (data not shown).
Negative signaling (see case 2b above) may be involved,
given that stimulation by OKT3a or OKT3 was prevented by
wt31 plus Leu3a pretreatment (Fig. 2 D). This negative effect
was not due to a significantly decreased binding of the sec-
ondary stimulating agents since labeling with the second step
Abs was not affected by incubations in the first step, as
judged by flow cytometry. This negative effect was abol-
ished when the low-affinity wt31 Ab was washed off the cells
after the first incubation step (data not shown). These data
imply that the suppressive effect is generated at an early step
of activation and involves some kind of interaction between
CD3 and CD4.
TABLE 2 Suppression of antl-CD3-lnduced T cell activation
by antl-CD4 Aba of different epltope specificities (activation
measured by thymidine Incorporation; see Materials and
Methods)
Stimulation Change
Leu4 wt31 Other Treatment %
+ Leu3a +25.0
+ Leu3a -85.3
+ OKT4 -36.0
+ OKT4 +19.6
+ 463 +17.3
+ 463 +38.8
+ 818 +16.3
+ 818 +19.7
+ SimA -74.7
+ OKT4a -80.0
OKTIa Leu3a +17.0
OKTI Leu3a -8.0
UCHT1 Leu3a -86.0
87654
+* +* +* +*
+*
+* +* +* +* +*
3
30
o
35
70 ,--------------,
o 0.5 5.0 50
Leu3a Ing/ml]
o
gp gp"'X
60 ,----------------,
c
B
A 70
35
o 100
(%) 50
2
wt31 and Leu4 (compare, e.g., Fig. 2, A-C with D). Acti-
vation appears to be blocked by Leu3a at an early stage (Fig.
2 C); accordingly, the early [Caif+ increment evoked by
FIGURE 2 Effect of CD4 ligands on anti-TCRlCD3-induced T cell ac-
tivation in human PBL cultures. Cells were harvested after 3 days of in-
cubation with the ligands, with 3H-thymidine added in the last 4 h. y axis:
dpm in thousands. (A) PBL stimulated with anti-CD3 Abs in the absence
or presence of Leu3a (used at the concentrations shown). Leu4 (5 nglml):
black bars; wt31 (applied at 50, 5, and 0.5 nglml concentration): gray,
hatched, and cross-hatched bars, respectively. (B) PBL stimulated with wt31
(black bars; Ab used at a concentration of 25 nglml), in the presence of
gp120-HSY alone (gp; applied at 1 /Lglml), together with anti-HSY Ab 5B6
(gp + X; see Banda et aI., 1992) used at 5 /Lglml) or without these additions
(-). In parallel experiments Leu3a was also included during incubation
(gray bars; Leu3a used at 50 nglml). (C) PBL stimulated with wt31 (25
nglml); with Leu3a (50 nglml) added after wt31 at the times indicated. SE
was as indicated by the bars, with similar values (not shown) in the other
panels. (D) PBL were fIrst incubated (1 h at 37°C, in complete medium)
with the Abs indicated (*; 12.5 nglml); then the second inducer Ab* was also
added (OKTIa (black bars) or OKTI (hatched bars), both used at 12.5
nglml) as shown in the tabulation below. Thymidine incorporation was
measured after 3 days of incubation with the second Ab (means of three
experiments shown). 100% = 160,000 dpm.
wt31 +* +*
Leu3a +*
OKTIa/OKTI
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FIGURE 3 (Upper panel) Flow-cytometric dot plot of PBL labeled with
wt31-FITC and Leu3a-PE (C03, FLI and CD4, FL2, respectively; X-Y
scale: log-log). Window shows the subpopulation of double-positive cells
selected for flow-sorting. Lower panel. Dot plot representation of pFRET
data. T
,vg is plotted as a function of FL2, combining the photobleaching data
obtained from D-only (left group of filled squares) and (0 + A)-labeled cells
(right group of squares). Linear X-Y scale (arbitrary units).
are incongruous in the context of the currently most-favored
interpretation (see Julius et aI., 1993 for review) that an
Ab-evoked spatial sequestration of CD4 is responsible for
this example of immune suppression. The data favor a model
(2b, above) where an improper apposition of CD4 with TCR/
CD3, forced by the binding of both wt31 and Leu3a distorts
the whole complex (or agglomerate of complexes), and im-
pairs positive signaling by additional anti-CD3 Abs. Thus,
the cases of negative signaling via CD4 (Julius et aI., 1993)
may be due to functional uncoupling rather than physical
separation of CD4 + p56lck from TCR/CD3. The fact that
CD4 and the CD3 E chain can be coprecipitated by anti-CD4
Abs (i.e., anti-CD4 does not induce the in vitro disso-
ciation of the complex; see Burgess et aI., 1991) supports
our findings.
The anti-CD4 and anti-CD3 Abs could sterically prevent
the approximation and direct contact of the Ags by their
direct bumping into each other, indicated by the significant
energy transfer between the Abs. In this case, the Ag-Ag
separation should be within a range of -10-20 nm, pre-
venting their direct contact. This situation is functionally
DISCUSSION
The high CD4-TCR/CD3 E (and E') values (close to the
maximal intramolecular E values measured in this system
(Szab6 et al., 1992a, b) in the presence of CD4 cross-linking
normalized within the compared set of samples for actual
labeling differences (corrected E values; see Materials and
Methods). It is to be emphasized that fluorescence labeling
was part of the treatment and cell stimulation schedule (see
Materials and Methods and Table 1 legend), ensuring that the
observed topology was biologically relevant. The high Eval-
ues between OKT3a-FITC and Leu3a-PE before stimulation
(Table 1, experiments 1-4) implied significant CD4-TCR/
CD3 association on resting cells, supporting the validity of
recent coprecipitation and affinity chromatography data (see
Suzuki et ai., 1992; for conflicting data see Gallagher et ai.,
1989). A further increase in E with activation confirmed the
current dogma on the association of CD4 and TCR/CD3 be-
coming more complete upon stimulation (Mittler et ai., 1989;
Rojo et aI., 1989; Kupfer et aI., 1987). Moreover, E between
CD4 and TCR/CD3 was maintained at its high post-
stimulation level in the presence of Leu3a-PE (applied both
as A and for treatment), strongly arguing against model l.
The flow-cytometric FLl/FL2 distribution of wt31-FITC/
Leu3a-PE (specific for CD3 and CD4, respectively) stained
PBL, with the subpopulation sorted for pFRET marked, is
shown in Fig. 3 (upper panel). Monitoring FL2, as well as
FLl in the bleaching experiment (see also Materials and
Methods) allowed us to view the data in a scattergram rep-
resentation, as in Fig. 3 (lower panel). The prolonged Tavg
values of most FL2-positive cells agree with a significant
level of CD3-CD4 energy transfer that shows no obvious
population heterogeneity. Cross-linking by Leu3a (experi-
ment 8) or through gp120 (experiments 5-7) even increased
CD4-CD3 juxtaposition when E' was measured, in the op-
posite direction (from CD4 to CD3) (experiments 5-8) and
between the particular Abs also used in the stimulation ex-
periment (experiment 8). In contrast, there was no energy
transfer from OKT3a toward CD45RO-PE (experiment 9),
which was in accordance with flow-cytometric FRET data
(Mittler et aI., 1991).
Experiments 10-12 of Table 1 support the possibility that
the proper steric arrangement within the TCR/CD3/CD4
complex might be hindered by CD4 cross-linking, given that
E and E' between wt31 and Leu3a was greater than between
Leu4 and Leu3a, suggesting a higher degree of proximity
between the antagonizing Abs. In contrast (experiment 13),
the OKT4E Ab (binding to an epitope opposite to the gp120
site (see Szab6 et ai., 1992b» appears to be much closer to
Leu4 than to UCHT1 (wt31-like in terms of Leu3a-
sensitivity, see Table 2), suggesting a position-sensitive
steric arrangement of the Ags. Therefore, the Ab wt31 (or
UCHT1) is either in a more intimate steric relationship
with the suppressor Ab than is Leu4, or wt31 is prefer-
entially bound to CD3rrCR molecules more intimately
involved with CD4.
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equivalent to the steric distortion of the complex (with CD4
and TCR/CD3 juxtaposed) when CD4-p561ck becomes dis-
engaged from TCR/CD3. Beyond these strictly mechanistic
considerations, it is also possible that the proximity rela-
tionships correlate with the tightness of CD4-p561ck anchor-
age, and thus affect activation indirectly.
The fact that suppression is released by washing off of
wt31 (data discussed above) raises the possibility that the
inhibitory effect involves a negative signal generated by
the wt31 + Leu3a-distorted TCR/CD3/CD4 complex. Since
the different domains of lck have distinct functions that may
independently contribute to T cell activation (Xu and Litt-
man, 1993), such a scenario is not at variance with the context
of prevailing biochemical evidence. The versatility of pos-
sible interactions through the kinase SH2 and SH3 domains
and the disparate roles of the possible phosphorylation sites
generate a complexity compatible with alternate induction
pathways, including negative signaling (see Xu and Littman,
1993; Luo and Sefton, 1990; Burgess et aI., 1991). Our re-
sults suggest that the interaction of TCR/CD3 components
with CD4 must be sterically coordinated (in vivo by MHC
class II Ags) for activation signaling (in line with the recent
molecular model described in Langedijk et aI., 1993) and also
provide a mechanistic framework for the possibility (Banda
et aI., 1992; Mittler and Hoffmann, 1989; Weinhold et aI.,
1989) that CD4 cross-linking may have a role in AlDS-
related immunosuppression.
The wt31!Leu4 binding sites on PBL may be heteroge-
neous, given that less wt31 bind than Leu4 upon saturation
(-50% in PBS at O°C, or -30% in complete medium at
37°C, with the calculation based on the labeling ratios for
these mAbs and also verified by indirect staining). Therefore,
it is possible that wt31 recognizes a subpopulation of the CD3
E chains, whereas Leu4 may bind to all E chains. If those Leu4
binding sites not accessible to wt31 are not intimately as-
sociated with CD4, the overall CD4-CD3 distance calculated
by pFRET will appear longer (see, e.g., experiments 10-12).
As there are more TCR/CD3 complexes than CD4s (-2X,
data not shown), there will be no donors without acceptors
upon complete association in the CD4-to-TCR/CD3 FRET
experimental arrangement. Our method measures E on the
donor side, making this approach (see experiment 8) sensi-
tive exclusively to changes in CD4-TCR/CD3 intimacy (see
Materials and Methods). In cocapping experiments per-
formed on the image analyzer, line scans across different
sections of the cells revealed an overlap between the OKT4-
and Leu4-labeled structures, the overlap being restricted to
certain domains of the membrane, suggesting that the two
TCR/CD3 subpopulations were situated in distinct mem-
brane domains (data not shown). Furthermore, it is possible
that wt31 binds in a monovalent, but Leu4 in a bivalent fash-
ion, since wt31 tends to dissociate from PBL cells upon
washing the cells with complete medium performed at room
temperature, in contrast with Leu4 (or Leu3a). It is easily
imagined that monovalent binding may be more sensitive to
possible steric restraints, imposed e.g., by an Ab binding to
CD4. Steric hindrance within the TCR/CD3/CD4 complexes
could prevent initiation of cell activation via these com-
plexes. Inappropriate (for stimulation) interaction between
Leu3a-engaged CD4 and wt31-bound TCR/CD3 may invoke
negative signaling.
The question whether T cell suppression by CD4 cross-
linking involves wide spatial sequestration of the Ag or if it
is due to more subtle forms of steric hindrance is answered
by the data above, directly and in an essentially nonperturb-
ing experimental situation. The pFRET technique, probably
the most sensitive method developed so far, allowed us to
measure intermolecular distances on the surface of human
PBL. Surprisingly, cross-linked CD4 stays in the molecular
vicinity of TCR, challenging the sequestration hypothesis,
visualized as a wide spatial separation of the Ags involved,
and supporting the view that an adequate steric apposition of
CD4 and the TCR/CD3 complex is required for activation
signaling.
Various modifications of our earlier technique (Szabo
et aI., 1992a, b, 1993) have contributed to the accuracy ofour
pFRET measurements. Flow-sorting served to increase the
efficiency of our measurements (approximately every fourth
PBL is expected to be CD4-positive) and helped decrease the
biological variation of D/A ratio. Recording FL2 intensity
enabled us to analyze our data on FL2/FL1 dot plots (scat-
tergrams) created in the worksheet program. The FL1 decay
times could be compared with the relative D/A labeling ratio
of the individual cells in a manner similar to a flow-
cytometric dot plot (Fig. 3), providing information on con-
spicuous population heterogeneities. The normalization pro-
tocol introduced here enabled us to interpret changes of the
energy transfer efficiency (as observed by this D-sided FRET
method) in terms of topological changes. It must also be
emphasized that the labeled antibodies were applied in rela-
tively low doses, as part of the stimulation experiments, in
culture conditions; therefore, the observed topology is as-
sumed to be biologically relevant.
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